Welcome to LookChem.com Sign In|Join Free
  • or
2,2-DIPHENYL-N-(2,2,2-TRICHLORO-1-[3-(4-FLUORO-3-NITROPHENYL)THIOUREIDO]ETHYL)ACETAMIDE, also known as CGK733, is a thiourea-containing compound that acts as a specific inhibitor of ataxia telangiectasia-mutated (ATM) protein/kinase. It is involved in the DNA damage response pathway in cells and plays a crucial role in cell cycle arrest, DNA repair, induction of premature senescence, and cell death. CGK733 has been identified as a cell proliferation inhibitor and an anticancer agent.

905973-89-9

Post Buying Request

905973-89-9 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

905973-89-9 Usage

Uses

Used in Anticancer Applications:
2,2-DIPHENYL-N-(2,2,2-TRICHLORO-1-[3-(4-FLUORO-3-NITROPHENYL)THIOUREIDO]ETHYL)ACETAMIDE is used as an anticancer agent for its ability to inhibit the ATM protein/kinase, which is involved in the DNA damage response pathway in cells. By suppressing ATM-mediated p21 expression required for survival in prematurely senescent breast, lung, and colon cancer cells, CGK733 results in cell death. Additionally, when used in combination with caffeine, it leads to a rapid decline in cyclin D1 protein levels and a reduction in retinoblastoma protein levels, inhibiting the proliferation of human cancer cell lines.
Used in Enhancing the Therapeutic Capacity of Genotoxic Anti-Cancer Regimens:
2,2-DIPHENYL-N-(2,2,2-TRICHLORO-1-[3-(4-FLUORO-3-NITROPHENYL)THIOUREIDO]ETHYL)ACETAMIDE is used as a strategy to increase the therapeutic capacity of certain genotoxic anti-cancer regimens by sensitizing cancer cells to these agents. Inhibiting the ATM and ATMand Rad3-related (ATR) kinases signaling pathway with CGK733 can activate cell cycle arrest, DNA repair, induction of premature senescence, and cell death, making cancer cells more susceptible to the effects of genotoxic agents.

Biological Activity

Originally defined as a selective inhibitor of ATR and ATM kinases that reverses senescence in human BJ and HMEC cells. Decreases p21 CIP1 levels in senescent with no effect on p53 and Bcl-2 family members.

Check Digit Verification of cas no

The CAS Registry Mumber 905973-89-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,0,5,9,7 and 3 respectively; the second part has 2 digits, 8 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 905973-89:
(8*9)+(7*0)+(6*5)+(5*9)+(4*7)+(3*3)+(2*8)+(1*9)=209
209 % 10 = 9
So 905973-89-9 is a valid CAS Registry Number.
InChI:InChI=1/C23H18Cl3FN4O3S/c24-23(25,26)21(30-22(35)28-16-11-12-17(27)18(13-16)31(33)34)29-20(32)19(14-7-3-1-4-8-14)15-9-5-2-6-10-15/h1-13,19,21H,(H,29,32)(H2,28,30,35)

905973-89-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 15, 2017

Revision Date: Aug 15, 2017

1.Identification

1.1 GHS Product identifier

Product name 2,2-diphenyl-N-[2,2,2-trichloro-1-[(4-fluoro-3-nitrophenyl)carbamothioylamino]ethyl]acetamide

1.2 Other means of identification

Product number -
Other names ATM/ATR Kinase Inhibitor

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:905973-89-9 SDS

905973-89-9Upstream product

905973-89-9Downstream Products

905973-89-9Relevant academic research and scientific papers

ATM AND ATR INHIBITOR

-

Page/Page column 36, (2008/06/13)

The present invention relates to a urea compound of formula (1) and a pharmaceutically acceptable salt thereof having inhibitory activity of ATM and ATR. According to the present invention, the urea compound of formula (1) selectively binds to ATM and ATR, and thus specifically suppresses the function of ATM and ATR as protein kinase. Therefore, the urea compound according to the present invention can be used for controlling cell function and treating diseases, in connection with function abnormality in ATM and ATR

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 905973-89-9